Log in to save to my catalogue

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6938497

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

About this item

Full title

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2019-12, Vol.9 (1), p.20403-12, Article 20403

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The
p53
gene is an important tumour suppressor gene. Mutant
p53
genes account for about half of all lung cancer cases. There is increasing evidence for the anti-tumour effects of statins via inhibition of the mevalonate pathway. We retrospectively investigated the correlation between statin use and lung cancer prognosis using the Taiwan...

Alternative Titles

Full title

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6938497

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6938497

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-019-56532-6

How to access this item